Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bateman

Showing results (131-140 of 533) with videos related to

Pageof 54
Sort By:
Acta Neuropathologica Communications|August 29, 2020
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brainKanta Horie, Nicolas R Barthélemy, Nipun Mallipeddi, et al.
Nature Reviews. Neurology|November 3, 2025
Towards pharmacological prevention of Alzheimer diseaseJorge J Llibre-Guerra, Eric M McDade, Suzanne E Schindler, et al.
Annals of Neurology|December 11, 2012
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controlsThomas J Esparza, Hanzhi Zhao, John R Cirrito, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2026
Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform TrialYan Li, Guoqiao Wang, Chengjie Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2014
Continuous 24-hour leptin, proopiomelanocortin, and amino acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and amino acid levelsSharon L Wardlaw, Charles F Burant, Samuel Klein, et al.
Rheumatology International|February 9, 2021
The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shieldingN Cleaton, S Raizada, N Barkham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populationsGuoqiao Wang, Yan Li, Eric McDade, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task ForceJ Cummings, K Blennow, K Johnson, et al.
British Journal of Haematology|October 1, 1975
Hypoplastic acute myelogenous leukaemiaM E Beard, C J Bateman, D C Crowther, et al.
Frontiers in Plant Science|March 17, 2020
Assessment of Mixed Sward Using Context Sensitive Convolutional Neural NetworksChristopher J Bateman, Jaco Fourie, Jeffrey Hsiao, et al.
Pageof 54

Showing results (131-140 of 533) with videos related to

Sort By:
Pageof 54
Acta Neuropathologica Communications|August 29, 2020
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brainKanta Horie, Nicolas R Barthélemy, Nipun Mallipeddi, et al.
Nature Reviews. Neurology|November 3, 2025
Towards pharmacological prevention of Alzheimer diseaseJorge J Llibre-Guerra, Eric M McDade, Suzanne E Schindler, et al.
Annals of Neurology|December 11, 2012
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controlsThomas J Esparza, Hanzhi Zhao, John R Cirrito, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2026
Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform TrialYan Li, Guoqiao Wang, Chengjie Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2014
Continuous 24-hour leptin, proopiomelanocortin, and amino acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and amino acid levelsSharon L Wardlaw, Charles F Burant, Samuel Klein, et al.
Rheumatology International|February 9, 2021
The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shieldingN Cleaton, S Raizada, N Barkham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populationsGuoqiao Wang, Yan Li, Eric McDade, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task ForceJ Cummings, K Blennow, K Johnson, et al.
British Journal of Haematology|October 1, 1975
Hypoplastic acute myelogenous leukaemiaM E Beard, C J Bateman, D C Crowther, et al.
Frontiers in Plant Science|March 17, 2020
Assessment of Mixed Sward Using Context Sensitive Convolutional Neural NetworksChristopher J Bateman, Jaco Fourie, Jeffrey Hsiao, et al.
Pageof 54